Navigation Links
Elekta European Users' Conference Attracts Top Minds in Cancer Management
Date:7/22/2011

STOCKHOLM, July 22, 2011 /PRNewswire/ -- Elekta users from Europe, Asia, the Middle East, North America and Africa converged on Hotel Hohe Dune in Warnemunde, Germany June 16-19 to participate in Elekta's fifth European Users' Conference. Approximately 390 clinicians and scientists attended 31 presentations and workshops given by Elekta users and company representatives on a wide range of cancer management topics. The Users' Conference was preceded by the Elekta Stereotactic Users' Meeting, June 15-16.

"We are pleased that the European Users' Conference has evolved to become an established, respected platform on which the absolute forefront of modern radiation therapy is discussed," says Olof Sanden, Executive Vice President, Europe and AFLAME. "This meeting continues to attract the most technologically and clinically sophisticated physicians and scientists in this region of the world to share experience and knowledge with peers."

The scientific program included presentations on:

  • The relative roles of 2D, 3D and 4D IGRT
  • The efficiency and precision of Volumetric Modulated Arc Therapy (VMAT)
  • MOSAIQ® Oncology Information System organization and management
  • Patient positioning and motion management
  • Single fraction and fractionated stereotactic cranial treatment with Leksell Gamma Knife® Perfexion™ and Extend™
  • Clarity® soft tissue visualization

Umberto Ricardi, M.D., radiation oncologist at the University Hospital of Turin was among several invited speakers. Dr. Ricardi discussed Turin's nine months of clinical experience with Elekta Axesse™ as a dedicated system for stereotactic radiation therapy and radiosurgery of body and brain tumors, and lately, spine tumors as well. Radiation delivery in most cases is with Elekta VMAT™.  

"We have treated 190 patients for a total of 210 lesions, and my impression is that the system is quite good – we really appreciate it," he says. "The HexaPOD™ table works very well – it's an indispensable component to our Axesse system, particularly for stereotactic radiation therapy using ablative doses. The table offers precise positioning in six axes. In addition, the iGuide® system provides accurate localization of the patient not only in body cases, but also for brain tumor cases as well. We also appreciate the ability to finely shape treatment fields with the 4 mm leaves of Beam Modulator™."

Two months ago, the University Hospital began using Elekta Axesse for SBRT of spine tumors, and has completed six cases. Clinicians are mirroring an RTOG protocol that employs a single fraction of 16 Gy.

Dr. Ricardi also gave a presentation on soft tissue IGRT, specifically the use of Clarity soft tissue visualization for patients with prostate cancer. "We are using it for patients who are candidates to receive radical treatments [i.e., radiation only] as a guide for hypofractionated radiation therapy," he says.

Having attended all five gathering of the Elekta European Users' Conference, Dr. Ricardi was impressed by the caliber of the 2011 meeting.

"The quality of the scientific program continues to increase – from a scientific standpoint and in the breadth of subject matter," he observes. "There were talks on general radiation oncology and specific presentations on cranial tumors, lung tumors, pediatric oncology and many others. The venue was great, as were the social aspects of the meeting. On a scale of 1 to 10, I give it a 10."

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Release of Elektas Monaco Treatment Planning System Prepares Software for Stereotactic Radiation Therapy
2. Latest Releases of Elektas XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer
3. Elektas Leksell Gamma Knife Perfexion is Ranked 2011s Best in KLAS for Radiation Therapy
4. National Comprehensive Cancer Network Guidelines Available in Elektas MOSAIQ EMR
5. Elektas MOSAIQ Far Ahead of Contenders in Black Book Rankings User Survey of EMR Vendors
6. Elekta and ScandiDos Sign Distributor Agreement for Pre-Treatment Verification Tool for Radiation Therapy
7. Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting
8. Elekta to Demonstrate Advanced Solutions for Managing Cancer Safely and Effectively at ESTRO 2011
9. Australian Center Readies Brain Research Program for Addition of Elekta MEG System
10. Elekta Emphasizes Advantages of Leksell Gamma Knife Perfexion Over Competing Systems at 2011 AANS Meeting
11. Elekta-sponsored Ceremony Honors Arizona Cancer Heroes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Now in its seventh year, the Pharmaceutical Innovation ... at developing and commercialising innovation. ... The Index can be summarised by ... different companies in early phase, which would make the best ... each company,s performance between 2011 and 2016, the 2017 ranking sees the ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies ... grow at a CAGR of 8.9% from 2016-2021 and CAGR of ... CAGR of 9.1% from 2016 to 2027. The market is estimated ... ... Read on to discover how you can exploit the future ...
(Date:2/27/2017)... and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... of June S. Almenoff , M.D., Ph.D., FACP, ... its Board of Directors.  "Dr. Almenoff ... whose appointments come at an exciting time for our ...
Breaking Medicine Technology:
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... March 7, 2017, from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. ... management, financial compliance, performance analytics, and engagement strategies. , The discussion will include ...
(Date:2/27/2017)... ... February 27, 2017 , ... It’s no secret ... often leads to a host of health issues, including urinary incontinence. However, results ... discovered that good overall muscle strength in older women, particularly in the ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Robert E. ... large medical group. But his impoverished upbringing and life experiences could have led him ... a Physician: Insightful and Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Much attention ... concern for women who become dependent on opioid painkillers has fallen short. From 1999 ... compared to a 237% increase in fatal overdoses in male populations.(1) , The proportion ...
(Date:2/27/2017)... ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from ... a nun. Now, she writes about God, when she isn’t swimming as a performing mermaid. ... Here is BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s ...
Breaking Medicine News(10 mins):